JTCS Speed Up Your Browser
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
G. Alexander Patterson
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kanaan, S. A.
Right arrow Articles by Patterson, G. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kanaan, S. A.
Right arrow Articles by Patterson, G. A.
Related Collections
Right arrow Lung - transplantation
Right arrow Molecular biology

J Thorac Cardiovasc Surg 2002;124:1130-1136
© 2002 The American Association for Thoracic Surgery


Cardiothoracic Transplantation (TX)

Intratracheal adenovirus-mediated gene transfer is optimal in experimental lung transplantation

Samer A. Kanaan, MD, Benjamin D. Kozower, MD, Takashi Suda, MD, Niccolò Daddi, MD, Tsutomu Tagawa, MD, Jon H. Ritter, MD, T. Mohanakumar, PhD, G. Alexander Patterson, MD, FRCS(C)

From the Division of Cardiothoracic Surgery, Department of Surgery, Washington University School of Medicine, St Louis, Mo.

Supported by National Institutes of Health grants R01 HL41281 (Dr Patterson) and R01 HL56643 (Dr Mohanakumar). Dr Kanaan is supported by Individual NRSA Fellowship 1 F32 HL68401-01.

Received for publication Nov 13, 2001. Revisions requested Jan 7, 2002; revisions received Jan 23, 2002. Accepted for publication Feb 20, 2002. Address for reprints: G. Alexander Patterson, MD, One Barnes-Jewish Hospital Plaza, 3108 Queeny Tower, St Louis, MO 63110 (E-mail: pattersona{at}msnotes.wustl.edu).

Objective: Gene transfer to experimental lung grafts has been shown to reduce ischemia-reperfusion injury and acute rejection. The optimal delivery route should produce high lung expression with no inflammation and minimal systemic expression. The goal of this study was to determine the optimal gene transfer route for use in experimental lung transplantation.
Methods: F344 rats were injected with 2.9 x 1010 plaque-forming units of adenovirus vector encoding ß-galactosidase through intratracheal, intravenous, intraperitoneal, or intramuscular delivery routes and killed 48 hours later. Gene expression was measured by means of enzyme-linked immunosorbent assay.
Results: Intratracheal delivery produces significantly greater gene expression in the lung (75,350 ± 47,288 pg/100 µg of protein, P < .001 vs intravenous, intraperitoneal, and intramuscular routes) and minimal systemic expression (nonsignificant in serum, kidney, liver, spleen, and muscle vs that seen in control animals, P = .016 for heart). Immunohistochemistry staining showed ß-galactosidase expression in the bronchial epithelium of lungs transfected through the intratracheal route with mild inflammation.
Conclusions: Intratracheal gene transfer provides significant expression in the lung with mild to no inflammation and minimal systemic expression. This delivery strategy has tremendous potential in experimental lung transplant models to reduce ischemia-reperfusion injury and acute allograft rejection and should be investigated further.




This article has been cited by other articles:


Home page
J. Thorac. Cardiovasc. Surg.Home page
T. Ishiyama, S. Dharmarajan, M. Hayama, H. Moriya, K. Grapperhaus, and G. A. Patterson
Inhibition of nuclear factor {kappa}B by I{kappa}B superrepressor gene transfer ameliorates ischemia-reperfusion injury after experimental lung transplantation
J. Thorac. Cardiovasc. Surg., July 1, 2005; 130(1): 194 - 201.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
T. Suda, N. Daddi, T. Tagawa, S. A. Kanaan, B. D. Kozower, J. H. Ritter, and G. A. Patterson
Recipient intramuscular cotransfection of transforming growth factor {beta}1 and interleukin 10 ameliorates acute lung graft rejection
J. Thorac. Cardiovasc. Surg., April 1, 2005; 129(4): 926 - 931.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
T. Tagawa, B. D. Kozower, S. A. Kanaan, N. Daddi, T. Suda, T. Oka, and G. A. Patterson
Tumor necrosis factor inhibitor gene transfer ameliorates lung graft ischemia-reperfusion injury
J. Thorac. Cardiovasc. Surg., October 1, 2003; 126(4): 1147 - 1154.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2002 by The American Association for Thoracic Surgery.